EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing O -Naphthylmethyl and O -Anthracenemethyl Glycosides as Metabolic Inhibitors of Bacterial Glycan Biosynthesis

Panhasith Ung, Ankita Paul, Soumyakanta Maji, Pilar Saavedra-Weis, Karen D Moulton, Suvarn S Kulkarni iD, Danielle H Dube iD

ACS Infectious Diseases · 13.02.2026 · 12 (2) · 544-554

DOI: 10.1021/acsinfecdis.5c00559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 22.09.2025. Verfasst von Panhasith Ung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry & Biochemistry, Bowdoin College, 2 Polar Loop, Brunswick, Maine 04011, United States. Hauptthemen laut MEDLINE: Glycosides, Anti-Bacterial Agents, Helicobacter pylori, Polysaccharides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Bowdoin College, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial glycans play a crucial role in survival and pathogenesis, making them attractive antibiotic targets. Unlike mammalian glycans, bacterial glycans incorporate rare sugars such as bacillosamine, N-acetylfucosamine, and 2,4-diacetamido-2,4,6-trideoxy galactose. To probe the role of bacterial glycans, we previously developed O-benzyl glycosides that metabolically inhibit Helicobacter pylori glycan biosynthesis and impair bacterial fitness. Here, we probed the efficacy of O-naphthylmethyl and O-anthracenemethyl glycosides, which bear larger aglycones relative to previously reported bacterial metabolic inhibitors. O-Naphthylmethyl d-N-acetylfucosamine inhibited H. pylori glycan biosynthesis, reduced biofilm formation, and impeded H. pylori growth at lower concentrations than its O-benzyl analog while leaving glycosylation of the commensal bacterium Bacteroides fragilis intact. By contrast, the O-anthracenemethyl glycosides tested were not effective metabolic glycan inhibitors. These metabolic inhibitors expand the bacterial glycoscience toolkit for probing protein glycosylation, help refine metabolic glycan inhibitor design parameters, and have the potential to set the stage for a glycan-based strategy to selectively target pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycosidesAnti-Bacterial AgentsHelicobacter pyloriPolysaccharidesGlycosylationBacteroides fragilisBiofilms

Stichwörter der Autor:innen

azidebioorthogonal chemistryglycaninhibitormetabolic labeling

Substanzen

GlycosidesAnti-Bacterial AgentsPolysaccharides

Autor:innen und Institutionen

  • Department of Chemistry & Biochemistry, Bowdoin College, 2 Polar Loop, Brunswick, Maine 04011, United States.
  • Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai 400-076, India.

ORCID-Profile: Suvarn S Kulkarni, Danielle H Dube

Förderung

  • NIGMS NIH HHS
  • Bowdoin College
  • Council of Scientific and Industrial Research, India
  • University Grants Commission
  • Science and Engineering Research Board
  • Ministry of Education, India
  • National Institute of General Medical Sciences

Zitieren

APA

Ung, P., Paul, A., Maji, S., Saavedra-Weis, P., Moulton, K. D., Kulkarni, S. S., & Dube, D. H. (2026). Assessing O -Naphthylmethyl and O -Anthracenemethyl Glycosides as Metabolic Inhibitors of Bacterial Glycan Biosynthesis. ACS Infectious Diseases, 12(2), 544-554. https://doi.org/10.1021/acsinfecdis.5c00559

Vancouver

Ung P, Paul A, Maji S, Saavedra-Weis P, Moulton KD, Kulkarni SS, et al. Assessing O -Naphthylmethyl and O -Anthracenemethyl Glycosides as Metabolic Inhibitors of Bacterial Glycan Biosynthesis. ACS Infectious Diseases. 2026;12(2):544-554. doi:10.1021/acsinfecdis.5c00559

BibTeX
@article{Ung2026,
  author = {Ung, Panhasith and Paul, Ankita and Maji, Soumyakanta and Saavedra-Weis, Pilar and Moulton, Karen D and Kulkarni, Suvarn S and Dube, Danielle H},
  title = {Assessing O -Naphthylmethyl and O -Anthracenemethyl Glycosides as Metabolic Inhibitors of Bacterial Glycan Biosynthesis},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {544--554},
  doi = {10.1021/acsinfecdis.5c00559}
}
Kostenlos starten →